Riskpilot← Back to searchSign inGet full accessARENDAL HUDKLINIKK AS
ASBankruptOrg 926853635Langbryggen 1, 4841 ArendalBeauty care and other beauty treatment activities · NACE 9622Est. 20216 employees
Revenue 2024
NOK 5,4M
+14% vs 2023
EBITDA margin
-0.1%
+98% vs 2023
Equity ratio
-44.6%
Financial strength
Net profit 2024
NOK -30K
+92% vs 2023
| Revenue | NOK 5,4M | +14% |
| EBITDA | NOK -8K | +98% |
| Net profit | NOK -30K | +92% |
| Total assets | NOK 1,2M | -19% |
| Equity | NOK -555K | -6% |
| Employees | 6 | — |
Legal name
ARENDAL HUDKLINIKK AS
Org number
926853635
Legal form
Aksjeselskap
NACE code
9622 · Beauty care and other beauty treatment activities
Founded
26. mars 2021
Share capital
NOK 30 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Salg av kosmetiske behandlinger, samt alt hva herved står i forbindelse.
Address
Langbryggen 1, 4841 Arendal
Phone
+4790645622
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 2 674 | 4 145 | 4 693 | 5 372 |
| Staff expenses | −954 | −1 472 | −1 870 | −2 273 |
| EBITDA | 18 | −196 | −447 | −8 |
| Depreciation & amort. | −8 | −25 | −25 | −25 |
| EBIT | 10 | −221 | −472 | −33 |
| Net financials | −1 | −0 | −9 | −3 |
| Profit before tax | 9 | −221 | −480 | −36 |
| Tax | 2 | −49 | −90 | −6 |
| Net profit | 7 | −172 | −390 | −30 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 1 013 | 1 193 | 1 539 | 1 245 |
| Equity | 37 | −135 | −525 | −555 |
| Long-term debt | 2 | 5 | 215 | 247 |
| Short-term debt | 974 | 1 323 | 1 849 | 1 553 |
| Total debt | 976 | 1 329 | 2 064 | 1 799 |
EBITDA margin
-0.1%
This company
15.8%
Market median
-101% vs market
20212024
Equity ratio
-44.6%
This company
38.2%
Market median
-217% vs market
20212024
Return on equity
-2953600.0%
This company
18.4%
Market median
-16052274% vs market
20212024
Net profit margin
-0.5%
This company
8.1%
Market median
-106% vs market
20212024
Asset turnover
4.32×
This company
1.12×
Market median
+286% vs market
20212024
Debt / equity
3.24×
This company
0.62×
Market median
-423% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HR Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 51% | 51% | 2022 | |
| Company | 49% | 49% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Snorø Holding As
ARENDAL HUDKLINIKK AS Board members of ARENDAL HUDKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henriette Røsberg | Chief Executive Officer | 0 companies |
| Sondre Martinsen Snortheimsmoen | Board of Directors | 0 companies |
| Einar Fosseli | Chairman | 0 companies |
| Elin Johanne Nordnes | Board of Directors | 0 companies |